Dr. Terence Ching is a licensed clinical psychologist and researcher at Yale University, where he leads psilocybin clinical trials for obsessive compulsive disorder (OCD) within the Emerging and Novel Applications for Consciousness-Altering Therapeutics (ENACT) Research Collaborative, which he describes as the flagship lab within the Yale Program for Psychedelic Science. There, he also serves as…

Source

Previous articlePα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin Use